Camber Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-10,150,000
| Closed | -$104M | – | 43 |
|
2023
Q3 | $104M | Buy |
10,150,000
+1,650,000
| +19% | +$16.8M | 3.41% | 10 |
|
2023
Q2 | $64M | Buy |
8,500,000
+5,500,000
| +183% | +$41.4M | 2.08% | 18 |
|
2023
Q1 | $26.6M | Sell |
3,000,000
-4,000,000
| -57% | -$35.4M | 0.82% | 21 |
|
2022
Q4 | $63.8M | Sell |
7,000,000
-500,000
| -7% | -$4.56M | 2.19% | 16 |
|
2022
Q3 | $60.5M | Buy |
7,500,000
+4,750,000
| +173% | +$38.3M | 1.85% | 19 |
|
2022
Q2 | $20.7M | Hold |
2,750,000
| – | – | 0.9% | 26 |
|
2022
Q1 | $25.8M | Hold |
2,750,000
| – | – | 0.93% | 26 |
|
2021
Q4 | $22M | Sell |
2,750,000
-2,250,000
| -45% | -$18M | 0.76% | 26 |
|
2021
Q3 | $48.7M | Sell |
5,000,000
-500,000
| -9% | -$4.87M | 1.5% | 22 |
|
2021
Q2 | $54.5M | Hold |
5,500,000
| – | – | 1.83% | 21 |
|
2021
Q1 | $63.5M | Buy |
5,500,000
+1,000,000
| +22% | +$11.5M | 2.18% | 16 |
|
2020
Q4 | $43.4M | Hold |
4,500,000
| – | – | 1.52% | 18 |
|
2020
Q3 | $40.5M | Buy |
4,500,000
+2,500,000
| +125% | +$22.5M | 2.14% | 18 |
|
2020
Q2 | $24.7M | Buy |
+2,000,000
| New | +$24.7M | 1.41% | 20 |
|
2020
Q1 | – | Sell |
-2,000,000
| Closed | -$19.6M | – | 33 |
|
2019
Q4 | $19.6M | Buy |
+2,000,000
| New | +$19.6M | 1% | 24 |
|
2019
Q3 | – | Sell |
-6,500,000
| Closed | -$60M | – | 35 |
|
2019
Q2 | $60M | Buy |
6,500,000
+3,000,000
| +86% | +$27.7M | 2.8% | 13 |
|
2019
Q1 | $54.9M | Buy |
+3,500,000
| New | +$54.9M | 2.73% | 15 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 39 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 36 |
|
2017
Q3 | – | Sell |
-5,266,450
| Closed | -$175M | – | 27 |
|
2017
Q2 | $175M | Buy |
5,266,450
+50,000
| +1% | +$1.66M | 8.52% | 1 |
|
2017
Q1 | $167M | Buy |
5,216,450
+492,000
| +10% | +$15.8M | 6.79% | 1 |
|
2016
Q4 | $171M | Buy |
4,724,450
+724,450
| +18% | +$26.3M | 8.92% | 1 |
|
2016
Q3 | $184M | Buy |
4,000,000
+1,130,000
| +39% | +$52M | 8.09% | 1 |
|
2016
Q2 | $144M | Buy |
2,870,000
+620,000
| +28% | +$31.1M | 6.97% | 1 |
|
2016
Q1 | $120M | Buy |
2,250,000
+450,000
| +25% | +$24.1M | 7.05% | 1 |
|
2015
Q4 | $118M | Sell |
1,800,000
-200,000
| -10% | -$13.1M | 7.63% | 1 |
|
2015
Q3 | $113M | Buy |
2,000,000
+250,000
| +14% | +$14.1M | 9.67% | 1 |
|
2015
Q2 | $103M | Buy |
1,750,000
+100,000
| +6% | +$5.91M | 7.04% | 1 |
|
2015
Q1 | $103M | Sell |
1,650,000
-100,000
| -6% | -$6.23M | 7.34% | 1 |
|
2014
Q4 | $101M | Hold |
1,750,000
| – | – | 6.69% | 1 |
|
2014
Q3 | $94.1M | Hold |
1,750,000
| – | – | 8.84% | 1 |
|
2014
Q2 | $91.7M | Buy |
1,750,000
+100,000
| +6% | +$5.24M | 6.01% | 1 |
|
2014
Q1 | $87.2M | Sell |
1,650,000
-350,000
| -18% | -$18.5M | 6.83% | 1 |
|
2013
Q4 | $80.2M | Hold |
2,000,000
| – | – | 7.07% | 1 |
|
2013
Q3 | $75.6M | Buy |
2,000,000
+1,250,000
| +167% | +$47.2M | 7.92% | 1 |
|
2013
Q2 | $29.4M | Buy |
+750,000
| New | +$29.4M | 3.02% | 12 |
|